Pitney Bowes (NYSE: PBI) director adds 4,000 common shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Pitney Bowes director Brent D. Rosenthal reported an open-market purchase of 4,000 shares of Pitney Bowes common stock. The shares were bought at $10.225 each on March 13, 2026. After this transaction, he directly owns 9,000 Pitney Bowes shares, indicating a modest increase in his personal stake.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 4,000 shares ($40,900)
Net Buy
1 txn
Insider
Rosenthal Brent D
Role
Director
Bought
4,000 shs ($41K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,000 | $10.225 | $41K |
Holdings After Transaction:
Common Stock — 9,000 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did Pitney Bowes (PBI) disclose for Brent D. Rosenthal?
Pitney Bowes disclosed that director Brent D. Rosenthal bought 4,000 shares of common stock in an open-market transaction. The purchase was reported on Form 4 and reflects a personal increase in his direct equity position in the company.
Is the Brent D. Rosenthal Pitney Bowes (PBI) transaction a purchase or sale?
The Form 4 shows that Brent D. Rosenthal executed a purchase of Pitney Bowes shares. The transaction code is “P,” meaning an open-market or private purchase, and the filing classifies the direction as a buy of 4,000 common shares.
Does Brent D. Rosenthal’s Pitney Bowes (PBI) trade involve derivatives or just common stock?
The reported transaction involves only Pitney Bowes common stock. The filing lists a non-derivative transaction for 4,000 shares and shows no accompanying derivative positions or option exercises in the derivative summary for this Form 4.